DISCOVERY LIFE SCIENCES Executive and Leadership Team

Gregory Herrema, the Chief Executive Officer at DISCOVERY LIFE SCIENCES, directs the overarching corporate strategy and long-term vision for the organization. By aligning internal scientific capabilities with the evolving needs of the global pharmaceutical and biotechnology sectors, Herrema ensures the company maintains a competitive edge in biospecimen procurement and genomic research. This leadership role involves constant engagement with the Board to optimize capital allocation and drive sustainable growth across international markets. Overseeing the integration of HudsonAlpha Discovery into the broader service portfolio, the Chief Executive Officer fosters an environment of innovation and operational excellence. Gregory Herrema prioritizes the expansion of diagnostic service offerings to support translational research initiatives worldwide. Through rigorous focus on market positioning and client-centric service models, the Chief Executive Officer secures the company's status as a premier partner for complex clinical research programs, ultimately accelerating the delivery of life-saving therapies to patients.

Jay Scherer, the Chief Operating Officer at DISCOVERY LIFE SCIENCES, manages the daily execution of global biospecimen distribution and laboratory operations. By streamlining supply chain logistics and enhancing laboratory throughput, Scherer ensures that complex research projects receive high-quality biological materials with maximum efficiency. This role requires close collaboration with technical teams to maintain rigorous quality standards across all sequencing and bioinformatics workflows. Jay Scherer oversees the infrastructure necessary to support large-scale clinical trials, ensuring that operational capacity scales alongside increasing demand from the diagnostics industry. By implementing advanced process automation, the Chief Operating Officer reduces turnaround times for critical research data. Scherer drives operational excellence by refining internal protocols and optimizing resource allocation across all global facilities. Through this focus on operational precision, the Chief Operating Officer enables the company to meet the demanding timelines of pharmaceutical partners while maintaining the highest levels of scientific integrity and data accuracy.

McLean Collins, the President, Biospecimens Products & Services at DISCOVERY LIFE SCIENCES, oversees the end-to-end lifecycle of the company's core biospecimen offerings. By managing the procurement, processing, and distribution of high-quality biological samples, Collins ensures that researchers have access to the precise materials required for translational and clinical studies. This role involves directing the strategic expansion of the biospecimen portfolio to include diverse and rare sample types that meet the evolving needs of the biotechnology industry. McLean Collins collaborates with scientific teams to integrate advanced analytical services with sample procurement, providing a comprehensive solution for complex research challenges. By optimizing the global supply chain and maintaining strict regulatory compliance, the President, Biospecimens Products & Services guarantees the reliability and quality of all distributed products. Collins drives the growth of this division by identifying emerging research trends and aligning product development with market demand. Through this leadership, the President, Biospecimens Products & Services enables the company to remain a critical partner in the global research ecosystem.

Tamara Bowles, the Chief Human Resources Officer at DISCOVERY LIFE SCIENCES, architects the talent acquisition and organizational development strategies necessary to support a high-growth scientific enterprise. By cultivating a culture of innovation and technical expertise, Bowles ensures the company attracts and retains top-tier talent in genomics, bioinformatics, and clinical research. This leadership role involves designing comprehensive performance management systems that align individual contributions with the broader mission of accelerating medical discovery. Tamara Bowles oversees all aspects of employee engagement, professional development, and organizational design to maintain a high-performance workforce across global operations. By implementing robust human capital initiatives, the Chief Human Resources Officer fosters an inclusive environment that encourages collaborative problem-solving among diverse scientific teams. Bowles drives the strategic alignment of workforce capabilities with the company's long-term business objectives. Through this focus on human capital, the Chief Human Resources Officer ensures the organization possesses the specialized expertise required to lead the biospecimen and sequencing markets.

Steve Hagan, the Chief Sales Officer at DISCOVERY LIFE SCIENCES, directs the global commercial strategy and revenue growth initiatives for the organization. By building deep, consultative relationships with pharmaceutical and biotechnology clients, Hagan ensures the company effectively communicates the value of its biospecimen and genomic sequencing services. This role involves leading high-performing sales teams to identify new market opportunities and expand the company's footprint in the clinical research sector. Steve Hagan oversees the development of tailored service packages that address the specific research obstacles faced by diagnostic partners. By analyzing market trends and competitive dynamics, the Chief Sales Officer refines the commercial approach to maximize market penetration and client retention. Hagan drives revenue performance by aligning sales efforts with the company's technical capabilities and service offerings. Through this strategic focus on commercial growth, the Chief Sales Officer secures long-term partnerships that support the company's mission of accelerating the pace of scientific discovery and medical innovation.